BioTuesdays

Tag - SEEL

Seelos Therapeutics Logo

Cantor starts Seelos Therapeutics at OW; PT $10

Cantor Fitzgerald launched coverage of Seelos Therapeutics (NASDAQ:SEEL) with an “overweight” rating and 12-to-18 month price target of $10. The stock closed at $3.08 on May 28. Analyst Charles Duncan, Ph.D., writes...

Seelos Therapeutics Logo

BTIG starts Seelos Therapeutics at buy; PT $14

BTIG initiated coverage of Seelos Therapeutics (NASDAQ:SEEL) with a “buy” rating and $14 price target. The stock closed at $3.04 on March 11. Seelos’ lead clinical candidate, SLS-002, is an intranasally delivered...